Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wedbush Maintains Outperform on Comerica, Lowers Price Target to $84

Wedbush analyst David Chiaverini maintains Comerica (NYSE:CMA) with a Outperform and lowers the price target from $95 to $84.
byBenzinga Newsdesk
October 20, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Wedbush analyst David Chiaverini maintains Comerica (NYSE:CMA) with a Outperform and lowers the price target from $95 to $84.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Gold, Precious Metals Dominate Real-World Assets On Blockchain: Is This A Sign Of Things To Come?

By Murtuza Merchant
September 14, 1:37 PM
In a significant development for the digital assets space, the value of real-world assets (RWAs) on-chain achieved a new milestone, reaching an all-time high of $3.1 billion as of Sept. 1, according to research. This surge in value surpasses the previous record of $2.75 billion set in April 2022 by a notable 13%.

ETH

Read More

Morningstar Trims Tilray’s Price Target, Here’s What’s Behind It

By Jelena Martinovic
February 20, 2:33 PM
Morningstar reduced its price target for Tilray Brands, Inc. (NASDAQ: TLRY) from $3.30 to $3.10, on Wednesday, Feb 14, all while keeping its four-star rating intact. According to Kristoffer Inton, the analyst, three reasons contributed to the price decline, including reduced revenue in the short term driven by ongoing market fragmentation, pricing compression, and still present illicit market in Canada."We forecast CAGR for net revenue from cannabis to be roughly 8% through fiscal 2033," the analyst said. "Our forecast is based on moderate price increases of roughly 3% per year, with weaker price growth in the Canadian recreational market due to Canadian consumers' preference for value over premium."

CSE:MMEN